• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Alistair Macdonald to be INC’s new CEO

Alistair Macdonald to be INC’s new CEO

July 29, 2016
CenterWatch Staff

INC Research Holdings, a global phase I to IV CRO, has announced that Chief Executive Officer Jamie Macdonald will transition his role as CEO of the company effective October 1, to INC Research’s current President and COO Alistair Macdonald.

Alistair Macdonald, who has served as INC’s President and COO since January 2013 and held various other leadership roles at the Company since 2002, will become a member of the company’s board of directors on October 1. Jamie Macdonald will step down from the board of directors at that time and will continue as vice chairman to assist in the transition of his CEO responsibilities until February 28, 2017, reporting to the chairman of the board of directors. 

"Alistair Macdonald brings strong leadership, a proven track record of success and strategic vision that we believe will guide the future growth and success of INC Research," said David Norton, chairman of the board. "As COO, Alistair has demonstrated outstanding leadership in strengthening INC's operations globally and we believe will drive increased opportunities for the company. We’re delighted to have such a strong successor to Jamie.”

Norton also thanked Jamie Macdonald for leading INC Research as CEO since 2013. “Jamie has guided INC and been a strong partner to our board over the last five years. During that time, he led the company through its successful IPO in 2014 and subsequent strong operational and market performance, and has been a leader in every sense. Since Jamie became CEO in 2013, INC has delivered industry-leading growth and margins. We are delighted that Jamie will be working with Alistair and the board to ensure a smooth transition.” 

Jamie Macdonald added, “This year marks my 5th year anniversary with INC Research and it has been an exciting, rewarding and successful time. I committed to myself that I would re-evaluate my priorities at this time and am fortunate that INC has in place a strong internal leadership team and successor to allow me to do that. I am proud to have led the company through a significant period of growth and look forward to assisting Alistair and the board with the transition as vice chair.”

Norton continued, “We respect Jamie’s decision to step away at this time and commend his commitment to his family and community, and want to thank him for supporting Alistair and the Company through its transition.”

Commenting on his new role, Alistair Macdonald added, “I am pleased to be appointed CEO of INC Research and look forward to working with Jamie and the Board over the transition period to support all of INC’s stakeholders moving forward. We have a strong leadership team in place and I look forward to continuing to enhance INC’s position as a top-tier CRO providing global phase I to phase IV clinical development services. I want to personally thank Jamie for his leadership over the last five years.”

Prior to assuming his current role as COO, Alistair Macdonald was president, Clinical Development Services for INC Research. Alistair has more than 20 years' of experience in the pharmaceutical industry and is based at the Company’s European Headquarters in Camberley, U.K.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing